Background image for footer

← Back to Blog

21 CFR Part 11 Compliant Software: What It Actually Requires

Share on LinkedIn
21 CFR Part 11 Compliant Software: What It Actually Requires

July 21, 2026

21 CFR Part 11 Compliant Software: What It Actually Requires

There is no such thing as FDA-certified Part 11 software. 21 CFR Part 11 is the FDA’s regulation for electronic records and electronic signatures — and compliance belongs to the organization running the system, not to the software alone. The right platform makes compliance achievable by design; your validation, procedures, and training are what make it real.

That distinction is the single most misunderstood thing about Part 11 — and it is where audit findings come from. This guide covers what the regulation actually requires, what a vendor can and cannot take off your plate, and what to look for when a submission date is on the calendar.

What does 21 CFR Part 11 actually require?

Part 11 applies to electronic records and signatures used to satisfy FDA predicate rules — the underlying regulations (GCP, GLP, GMP) that require the record in the first place. For clinical data systems, the core requirements group into three buckets:

Electronic record controls. System validation to demonstrate accuracy, reliability, and consistent intended performance; computer-generated, time-stamped audit trails that record the creation, modification, and deletion of records without obscuring prior values; the ability to generate accurate and complete copies for FDA inspection; and record retention for the full required period.

Access and accountability controls. System access limited to authorized individuals; authority checks that enforce who can do what; unique user credentials — no shared logins, ever; and operational checks that enforce required sequencing where it matters.

Electronic signature controls. Signatures must display the printed name of the signer, the date and time, and the meaning of the signature (review, approval, responsibility); they must be permanently linked to their record so they cannot be excised or copied; and each signature must be unique to one individual and never reused or reassigned.

Is there such a thing as “Part 11 certified” software?

No. The FDA does not certify, approve, or endorse software as Part 11 compliant — no such certification program exists. Any vendor claiming to be “FDA certified” is overreaching. What a credible vendor actually offers is software that is compliant-capable — built with the technical controls Part 11 requires — plus the documentation to support your validation of it.

Compliance is then a shared responsibility, split roughly like this:

The vendor’s side

Your side (the deploying organization)

Technical controls built in: audit trails, access management, e-signature manifestation and record linking

Written procedures (SOPs) governing system use, signature accountability, and record retention

Vendor-side validation and documented SDLC (software development life cycle)

Your validation of the system for its intended use in your studies

Separate environments for safe change management

User training, access provisioning, and periodic access review

Hosting, backup, and disaster-recovery controls

Signature policies — including the FDA letter of non-repudiation certification

A vendor that hands you validated software with no supporting documentation has given you half a compliance story — the half you can’t show an inspector.

How do you validate software for 21 CFR Part 11?

Validation under Part 11 follows standard computer system validation (CSV) logic: define intended use, assess risk, verify the system performs as intended, and document all of it. For SaaS clinical platforms, the practical model is leverage-and-supplement — the vendor supplies platform-level validation evidence (IQ/OQ documentation, release validation, SOPs), and you supplement with performance qualification against your own intended use.

What separates a fast validation from a slow one is almost entirely the quality of the vendor’s documentation package. If validation, certification, and SOP documentation arrive with every deployment and every release, your quality team reviews and adopts; if they don’t, your quality team authors from scratch — a difference measured in months.

What should a small biotech look for in Part 11 compliant software?

For a small sponsor or CRO without a large quality organization, the evaluation reduces to five questions:

  • Does the audit trail capture everything, automatically? Computer-generated, time-stamped, covering create/modify/delete, with prior values preserved — and readable by an inspector without vendor help.

  • Are e-signatures native, not bolted on? Name, date/time, and meaning displayed; signature bound to the record; re-authentication at signing.

  • What validation documentation ships with the system — and with each release? This is the time-and-cost question. Ask to see the package before you buy.

  • How is access actually controlled? Role-based permissions, PHI (Protected Health Information) access management, unique credentials, and provisioning you can administer yourself.

  • Are there separate environments? Build, UAT (user acceptance testing), and production separation is what makes mid-study change safe — and defensible.

How does REDCap Cloud support Part 11 compliance?

REDCap Cloud is a validated commercial EDC/CDMS (electronic data capture / clinical data management system) built for regulated research — which is a different product with a different burden of proof than the free academic REDCap that shares part of its name. The platform carries the technical controls above natively — full audit trails, native eSignature, role- and PHI-based access management — and ships validation, certification, and SOP documentation with every deployment. Build, UAT, and production run as separate environments, and platform updates apply without mid-study migration. The compliance envelope spans FDA 21 CFR Part 11, HIPAA, GDPR, GxP, ICH GCP E6(R3), and EU Annex 11, with SOC 2 Type II, ISO 27001/27017/27018, and HITRUST CSF certifications behind it.

If your study started life in academic REDCap and now has a regulated endpoint, that’s the exact progression covered in When open-source REDCap isn’t enough.

Frequently Asked Questions (FAQ)

Does the FDA certify software as Part 11 compliant?

No. The FDA does not certify or approve any software as Part 11 compliant. Vendors can build compliant-capable systems and supply validation documentation, but compliance is established by the organization deploying the system — through validation, procedures, and training.

What is an audit trail under 21 CFR Part 11?

A secure, computer-generated, time-stamped record of the creation, modification, and deletion of electronic records. Changes must not obscure previously recorded values, and the audit trail must be retained and available for FDA review for as long as the underlying record.

What is the difference between Part 11 compliance and computer system validation?

Computer system validation (CSV) is one requirement within Part 11 — documented evidence that a system does what it is intended to do. Part 11 compliance is broader: validation plus audit trails, access controls, record copies and retention, and electronic signature controls, supported by your organization’s procedures.

Does Part 11 apply to my study?

If you create, modify, store, or transmit electronic records required by an FDA predicate rule — or use electronic signatures on those records — Part 11 applies. Most interventional trials intended for FDA submission fall squarely in scope.

Clinical Research digital data wave background image

Book a Demo →

Start your journey with REDCap Cloud today – scale for tomorrows novel therapies.